LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 610

Search options

  1. Article ; Online: Complexity is the simple truth about Alzheimer's disease.

    Frisoni, Giovanni B

    The Lancet. Neurology

    2023  Volume 22, Issue 9, Page(s) 776–778

    MeSH term(s) Humans ; Alzheimer Disease
    Language English
    Publishing date 2023-07-13
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(23)00176-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Recycling brain scans with AI.

    Frisoni, Giovanni B

    Nature reviews. Neurology

    2023  Volume 19, Issue 6, Page(s) 327–328

    MeSH term(s) Humans ; Brain/diagnostic imaging ; Neuroimaging ; Artificial Intelligence
    Language English
    Publishing date 2023-03-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2491514-2
    ISSN 1759-4766 ; 1759-4758
    ISSN (online) 1759-4766
    ISSN 1759-4758
    DOI 10.1038/s41582-023-00799-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: From patients to disease: the difficult case of Alzheimer's.

    Frisoni, Giovanni B / Lathuilière, Aurelien

    The Lancet. Neurology

    2022  Volume 21, Issue 2, Page(s) 105–106

    MeSH term(s) Alzheimer Disease/diagnosis ; Diagnosis, Differential ; Humans
    Language English
    Publishing date 2022-01-20
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(21)00461-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: STRIVEing to describe small vessel disease.

    Frisoni, Giovanni B / van der Flier, Wiesje

    The Lancet. Neurology

    2023  Volume 22, Issue 7, Page(s) 548–549

    MeSH term(s) Humans ; Stroke ; Brain ; Cerebral Small Vessel Diseases/diagnostic imaging ; Magnetic Resonance Imaging
    Language English
    Publishing date 2023-05-23
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(23)00197-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Early termination of pivotal trials in Alzheimer's disease-Preserving optimal value for participants and science.

    Gietl, Anton F / Frisoni, Giovanni B

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2022  Volume 18, Issue 10, Page(s) 1980–1987

    Abstract: Participants in Alzheimer's disease late-phase clinical trials are frequently confronted with a situation of early termination. We discuss measures to protect the perceived value of study participation and to maximize the scientific value under such ... ...

    Abstract Participants in Alzheimer's disease late-phase clinical trials are frequently confronted with a situation of early termination. We discuss measures to protect the perceived value of study participation and to maximize the scientific value under such circumstances. A communication strategy should ensure that trial participants maintain a positive relationship with the research team and have their informational needs optimally met. Measures to maximize the scientific value may include data/sample sharing, strategies for personalized medicine, as well as scientific follow-up. Critical for the success of such a concept are networks of excellence, extending models of existing initiatives like Global Alzheimer's Platform Foundation Network (GAP-Net). These networks could fundamentally strengthen the role of clinical investigators if they decide on their involvement in trials based upon their estimation of the scientific value and benefit for the participants, actively contribute to scientific analyses, and mediate optimal communication among the relevant trial stakeholders.
    MeSH term(s) Humans ; Alzheimer Disease/drug therapy ; Communication ; Clinical Trials as Topic
    Language English
    Publishing date 2022-02-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1002/alz.12605
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Management of Alzheimer's disease takes a leap forward.

    Frisoni, Giovanni B / Hansson, Oskar

    The Lancet. Neurology

    2021  Volume 20, Issue 8, Page(s) 586–587

    MeSH term(s) Alzheimer Disease/epidemiology ; Alzheimer Disease/therapy ; Humans
    Language English
    Publishing date 2021-07-22
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(21)00198-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report.

    Mathoux, Gregory / Boccalini, Cecilia / Lathuliere, Aurelien / Scheffler, Max / Frisoni, Giovanni B / Garibotto, Valentina

    EJNMMI research

    2024  Volume 14, Issue 1, Page(s) 35

    Abstract: Background: This case report presents a patient with progressive memory loss and choreiform movements.: Case presentation: Neuropsychological tests indicated multi-domain amnestic mild cognitive impairment (aMCI), and neurological examination ... ...

    Abstract Background: This case report presents a patient with progressive memory loss and choreiform movements.
    Case presentation: Neuropsychological tests indicated multi-domain amnestic mild cognitive impairment (aMCI), and neurological examination revealed asymmetrical involuntary hyperkinetic movements. Imaging studies showed severe left-sided atrophy and hypometabolism in the left frontal and temporoparietal cortex. [
    Conclusions: Our case highlights that despite the lack of specific FUS biomarkers the combination of clinical features and neuroimaging biomarkers can guide choosing the most likely differential diagnosis in a complex neurological case. Imaging in particular allowed an accurate measure of the topography and severity of neurodegeneration and the exclusion of AD-related pathology.
    Language English
    Publishing date 2024-04-04
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2619892-7
    ISSN 2191-219X
    ISSN 2191-219X
    DOI 10.1186/s13550-024-01102-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations.

    Mercier, Camille / Rollason, Victoria / Eshmawey, Mohamed / Mendes, Aline / Frisoni, Giovanni B

    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

    2024  

    Abstract: Behavioural and psychological symptoms of dementia (BPSD) are a clinical challenge for the lack of a sound taxonomy, frequent presentation with comorbid BPSD, lack of specific pharmacologic interventions, poor base of methodologically sound evidence with ...

    Abstract Behavioural and psychological symptoms of dementia (BPSD) are a clinical challenge for the lack of a sound taxonomy, frequent presentation with comorbid BPSD, lack of specific pharmacologic interventions, poor base of methodologically sound evidence with randomized clinical trials, contamination from the treatment of behavioural disturbances of young and adult psychiatric conditions, and small efficacy window of psychotropic drugs. We present here a treatment workflow based on a concept-driven literature review based on the notions that (i) the aetiology of BPSD can be mainly neurobiological (so-called 'primary' symptoms) or mainly environmental and functional ('secondary' symptoms) and that this drives treatment; (ii) the clinical efficacy of psychotropic drugs is driven by their specific profile of receptor affinity; (iii) drug treatment should follow the rules of 'start low-go slow, prescribe and revise'. This article argues in support of the distinction between primary and secondary BPSD, as well as their characteristics, which until now have been just sketchily described in the literature. It also offers comprehensive and pragmatic clinician-oriented recommendations for the treatment of BPSD.
    Language English
    Publishing date 2024-04-18
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2213105-X
    ISSN 1479-8301 ; 1346-3500
    ISSN (online) 1479-8301
    ISSN 1346-3500
    DOI 10.1111/psyg.13116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes.

    Boccalini, Cecilia / Caminiti, Silvia Paola / Chiti, Arturo / Frisoni, Giovanni B / Garibotto, Valentina / Perani, Daniela

    Annals of clinical and translational neurology

    2024  

    Abstract: Objectives: Mild cognitive impairment presenting with an amnestic syndrome (aMCI) and amyloid positivity is considered due to AD. Many subjects, however, can show an overall very slow progression relevant for differential diagnosis, prognosis, and ... ...

    Abstract Objectives: Mild cognitive impairment presenting with an amnestic syndrome (aMCI) and amyloid positivity is considered due to AD. Many subjects, however, can show an overall very slow progression relevant for differential diagnosis, prognosis, and treatment. This study assessed PET biomarkers, including brain glucose metabolism, tau, and amyloid load, in a series of comparable aMCI at baseline, clinically evaluated at follow-up.
    Methods: We included 72 aMCI subjects from Geneva Memory Center (N = 31) and ADNI cohorts (N = 41), selected based on available FDG-PET, tau-PET, amyloid-PET, and clinical follow-up (2.3 years ± 1.2). A data-driven algorithm classified brain metabolic patterns into subtypes that were then compared for clinical and PET biomarker measures and cognitive decline. Voxel-wise comparisons were performed both with FDG-PET and tau-PET data.
    Results: The algorithm classified three metabolic subtypes, namely "Hippocampal-sparing with cortical hypometabolism" (Type1; N = 27), "Hippocampal and cortical hypometabolism" (Type 2; N = 23), and "Medial temporal hypometabolism" (Type 3; N = 22). Amyloid positivity and tau accumulation in the medial temporal and neocortical regions characterized Type 1 and Type 2, whereas Type 3 showed no significant tau pathology, variable amyloid positivity, and stability at follow-up. All tau-positive patients, independently of the FDG-based subtype, showed faster cognitive decline.
    Interpretation: aMCI subjects can differ in metabolic patterns, tau and amyloid pathology, and clinical progression. Here, we complemented with PET tau biomarker the specific brain hypometabolic patterns at the individual level in the prodromal phase, contributing to the patient's classification. Tau PET is the most accurate biomarker in supporting or excluding the AD diagnosis in aMCI across metabolic subtypes and also predicting the risk of decline.
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2740696-9
    ISSN 2328-9503 ; 2328-9503
    ISSN (online) 2328-9503
    ISSN 2328-9503
    DOI 10.1002/acn3.52039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Brain imaging working group summaries for the European Joint Programme for Neurodegenerative Disease Research.

    Frisoni, Giovanni B / Jovicich, Jorge

    Alzheimer's & dementia (Amsterdam, Netherlands)

    2019  Volume 11, Page(s) 67–68

    Language English
    Publishing date 2019-01-09
    Publishing country United States
    Document type Editorial
    ZDB-ID 2832898-X
    ISSN 2352-8729
    ISSN 2352-8729
    DOI 10.1016/j.dadm.2018.11.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top